Edward M. Basile


  • Tuesday, June 30, 2009
    On June 3, the U.S. Food and Drug Administration (FDA or Agency) announced the formation of the FDA Transparency Task Force (Task Force) to solicit public comments and to promulgate recommendations for enhancing the transparency of the FDA's internal activities and decision-making.1As part of its efforts to seek public input, the FDA has set up the FDA...